1057P Penpulimab combined with anlotinib as first-line chemotherapy-free regimen in elderly patients with advanced NSCLC: A phase II single-center study
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-05 10:23:43 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.annonc.2025.10.768
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0923753425057175
其他信息:
出版社: Elsevier BV
作者: Y. zhang; Y. Ji; X. Meng; W. Shen

